Oncology Drug Market : Global Industry Analysis and Forecast (2023-2029)

Oncology Drug Market size is expected to reach US$ 280.73 Bn. by year 2029 at a CAGR of 11.4% during the forecast period.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report
Oncology Drug Market Dynamics:
Global market is segmented on the basis of Therapeutic Modalities, Cancer types, and Geography. The increasing demand of biological and targeted drug therapies, the rising prevalence of various types of cancer, rising impact of biosimilars, and continuous patent expiry of key cancer drugs are the major factors driving the growth of Global market. However, the adverse effects of cancer drug therapy and a threat of failure, and the high cost of drug development are the key restraining factors for market growth.
Oncology Drug Market Regional Analysis:
Owing to the high efficacy of the drug based on monoclonal antibodies have gained attention in recent years, which is expected to further furl the growth of the market. Initiatives were taken by USFDA and European Union to fuel the growth of the global market by offering pre-market approval for potential drugs under clinical development. North America is anticipated to dominate the overall market, owing to the large presence of companies engaged in the development of cancer drugs. Europe is the second largest revenue generating region for global market.

The objective of the report is to present comprehensive assessment projections with a suitable set of assumptions and methodology. The report helps in understanding Global market dynamics, structure by identifying and analyzing the market segments and projecting the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, growth strategies, and regional presence. To understand the market dynamics and by region, the report has covered the PEST analysis by region and key economies across the globe, which are supposed to have an impact on market in forecast period. PORTER’s analysis, and SVOR analysis of the market as well as detailed SWOT analysis of key players has been done to analyze their strategies. The report will to address all questions of shareholders to prioritize the efforts and investment in the near future to the emerging segment in the Global market.
Oncology Drug Market Research Methodology:
The research methodology used in Global Oncology Drug Market report contains various secondary sources including directories such as a study of company websites, stock analysis presentation, national and international database, annual reports and press releases. Bloomberg, Hoovers, and Factiva are some of the sites that are being referred to gain insights about Automotive Temperature Sensor market. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of Global Oncology Drug Market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Oncology drug market globally.
Oncology Drug Market, Key Highlights:
Global Oncology drug market analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Oncology drug market

Global Oncology drug market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

Oncology drug market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Oncology drug market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Oncology drug market are also profiled.
Years that have been considered for the study are as follows:
Base Year - 2022
Estimated Year - 2022
Forecast Period - 2022 to 2029
For company profiles, 2022 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered
Research Methodology:
The research methodology used in Global market report contains various secondary sources including directories such as a study of company websites, stock analysis presentation, national and international database, annual reports and press releases. Bloomberg, Hoovers, and Factiva are some of the sites that are being referred to gain insights about Automotive Temperature Sensor market. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of Global market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global market globally.
Oncology Drug Market Key Target Audience:
Pharmaceutical and Biotechnological Companies
Venture Capitalists and Investors
Medical Research Laboratories
Hospitals and clinics
Research and Development Organizations
Business Research and Consulting Service providers
Drug Manufacturers and suppliers
Academic Research Institutes
Academic Medical Centers and universities
Government and regulatory authorities

Research report categorizes the Global Oncology Drug Market based on Therapeutic Modalities, Cancer Types, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Oncology Drug market with key developments in companies and market trends.
Oncology Drug Market Scope : Inquire before buying



Oncology Drug Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $ 131.85 Bn.


Forecast Period 2023 to 2029 CAGR:
11.4%
Market Size in 2029:
US $ 280.73 Bn.


 Segments Covered:
by Therapeutic Modalities
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal


by Cancer Type
Lung Cancer
Stomach Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Esophagus Cancer
Cervical Cancer
Kidney Cancer
Bladder Cancer
Other Cancers


by Drug Class
Cytotoxic Drugs
Alkylating Agents
Antimetabolites
Others
Targeted Drugs
Monoclonal Antibodies
Others
Hormonal Drugs
Others


by Dosage Form
Solid
Tablets
Capsules
Liquid
Injectable
Prefilled Syringes
Others


by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others



Oncology drug Market, By Geography:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key Players:
1. Pfizer
2. Merck and company
3. Novartis
4. Glaxo Smith Kline PLC
5. Johnson and Johnson
6. Amgen
7. Roche Diagnostics
8. Eli Lilly and company
9. Celgene Corporation
10.Sanofi
11.F. Hoffmann-La Roche AG
12.Bristol-Myers Squibb Company
13.AbbVie Inc.
14.Adcock Ingram
15.AdoRx Therapeutics
16.AID Genomics Limited
17.Apikos Pharma
18.AQVIDA GmbH
19.Arlak Biotech
20.Aspen
21.Astellas Pharma Inc
22.AstraZeneca plc
23.Bayer AG
24.BeiGene
25.CARsgen Therapeutics
Frequently Asked Questions:
1. Which region has the largest share in Global Oncology Drug Market?
Ans: Asia Pacific region holds the highest share in 2022.

2. What is the growth rate of Global Oncology Drug Market?
Ans: The Global Oncology Drug Market is growing at a CAGR of 11.4% during forecasting period 2023-2029.

3. What is scope of the Global Oncology Drug market report?
Ans: Global Oncology Drug Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Oncology Drug market?
Ans: The important key players in the Global Oncology Drug Market are – Pfizer, Merck and company, Novartis, Glaxo Smith Kline PLC, Johnson and Johnson, Amgen, Roche Diagnostics, Eli Lilly and company, Celgene Corporation, Sanofi, F. Hoffmann-La Roche AG, and Bristol-Myers Squibb Company.

5. What is the study period of this market?
Ans: The Global Oncology Drug Market is studied from 2022 to 2029.